Generation of Patient-derived IPSC Lines from a Girl with Combined Oxidative Phosphorylation Deficiency 23 (COXPD23) Caused by Compound Heterozygous GTPBP3 Variants
Overview
Authors
Affiliations
Combined Oxidative Phosphorylation Deficiency 23 (COXPD23) caused by mutations in GTPBP3 gene is a rare mitochondrial disease. The patient-derived PBMCs of sibling with the compound heterozygous variants in GTPBP3 (NM_133644): c.1289G>A(p.Cys430Tyr); c.545G>A(p.Gly182Glu) were reprogrammed into induced pluripotent stemcell (iPSC) lines (DPNJMUi001-A.) using non-integrative Sendai virus. The COXPD23 iPSC lines present normal karyotypes, high expression of pluripotency markers and the capacity to differentiate into cells of all three germ layers.
Xie Y, Li K, Yang L, Zeng X, Chen Z, Ma X Orphanet J Rare Dis. 2024; 19(1):488.
PMID: 39719609 PMC: 11668094. DOI: 10.1186/s13023-024-03469-3.
Wang Y, He J, Dong F, Shou W, Feng X, Yang Y Heliyon. 2024; 10(6):e27199.
PMID: 38515655 PMC: 10955198. DOI: 10.1016/j.heliyon.2024.e27199.
Biallelic variants in GTPBP3: New patients, phenotypic spectrum, and outcome.
Nardecchia F, Carrozzo R, Innocenti A, Torraco A, Zaccaria V, Rizza T Ann Clin Transl Neurol. 2024; 11(3):819-825.
PMID: 38327089 PMC: 10963292. DOI: 10.1002/acn3.51980.